Mirum Pharmaceuticals, Inc. (MIRM) vs Waystar Holding Corp. (WAY)

A side-by-side comparison of Mirum Pharmaceuticals, Inc. and Waystar Holding Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — MIRM vs WAY

growth of $100 · dividends reinvested · last 2y
MIRM +226.2% (+80.6%/yr)WAY +27.9% (+13.1%/yr)MIRM compounded faster over this window
100200300400500Start $10020252026$326$128
MIRM WAY

MIRM vs WAY: by the numbers

  • •WAY is the larger company ($5.06B vs $4.83B market cap).
  • •WAY is profitable (11.18% net margin) while MIRM runs a net loss (-139.18%).

Metrics side by side

Valuation

MetricMIRMWAY
P/E ratioN/A37.71
Forward P/EN/A15.81
P/S ratio7.824.20
P/B ratioN/A1.27
EV / EBITDAN/A15.10
FCF yieldN/A4.86%

Profitability

MetricMIRMWAY
Gross margin81.70%69.11%
Operating margin-4.25%22.87%
Net margin-139.18%11.18%
ROEN/A3.38%
ROIC-13.09%3.38%

Growth (annualized)

MetricMIRMWAY
Revenue CAGR (5Y)123.86%N/A
Total return CAGR (5Y)37.24%N/A

Frequently asked

Is MIRM or WAY more profitable?
WAY runs the higher net margin — MIRM at -139.18% versus WAY at 11.18%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.